Study links Ozempic to kidney failure prevention It found semaglutide reduced risk of major kidney events by 24% for type 2 diabetes patients, but GPs have urged caution.
Replica Ozempic and Mounjaro to be banned The Government has removed a loophole allowing the mass production of the compounded drugs amid growing patient safety concerns.
Report finds My Health Record ‘plagued’ with poor usability It also found automation of simple tasks could free up to 30% of clinicians’ time, and data sharing could save $5.4 billion.
Business of general practice: What’s the next thing? The keynote speaker at the RACGP’s practice owners conference wants to give GPs a plan for navigating disruption and building a strong business.
Warning issued on point-of-care testing compliance Despite thousands of MBS claims, the DoHAC understands no clinics are approved for the HbA1c test, sparking calls for practices to get accredited.
Sydney home raided after Ozempic scam The TGA is urging GPs ‘exercise deep caution’ after doctors were faxed ads promoting allegedly illegally compounded semaglutide.
How RACGP Foundation seed funding blossomed into MRFF grant What started as a small, GP-led diabetes research project recently received close to $1 million to expand into other areas of chronic disease.
In Practice: Updates to allied health MBS items Referral changes to MBS items for Aboriginal and Torres Strait Islander patients accessing allied health services are now in place.
Pharmacy diabetes trial creating ‘serious concerns’ The RACGP has slammed a plan to screen for the disease in pharmacies, saying it could fragment care and put vulnerable patients at risk.
Funding needed to ‘help share the workload’: RACGP Commonwealth support should be funnelled into expanding general practices to include multidisciplinary care teams, according to a college submission.